doi: 10.1161/hs0102.100877
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2002;33:136.)
© 2002 American Heart Association, Inc.
Original Contributions |
Effects of Hypertonic (10%) Saline in Patients With Raised Intracranial Pressure After Stroke
From the Departments of Neurology and Neurosurgery (A.A.), University of Heidelberg, Heidelberg, Germany.
Correspondence to Dr Stefan Schwarz, Department of Neurology, University of Heidelberg, 400 Im Neuenheimer Feld, Heidelberg 69120, Germany. E-mail stefan_schwarz{at}med.uni-heidelberg.de
Background and Purpose— The aim of this study was to evaluate the effects of hypertonic saline in stroke patients with increased intracranial pressure (ICP) after conventional therapy with mannitol had failed.
Methods— Twenty-two episodes of ICP crisis occurred in 8 patients in whom the standard treatment of 200 mL of 20% mannitol was not effective. ICP crisis was defined as an increase in ICP of 20 mm Hg (n=18), pupillary abnormality (n=3), or a combination of both (n=1). The patients were treated with 75 mL of 10% saline over the course of 15 minutes. ICP, mean arterial blood pressure, and cerebral perfusion pressure were monitored for 4 hours. Blood gases, hematocrit, hemoglobin, pH, osmolarity, and electrolytes levels were measured before and 15 and 60 minutes after the start of infusion. Treatment was regarded as effective if ICP decreased >10% or the pupillary reaction had normalized.
Results— Treatment was effective in all 22 episodes. The maximum ICP decrease was 9.9 mm Hg 35 minutes after the start of infusion. Thereafter, ICP began to rise again. There was no constant effect on mean arterial blood pressure, whereas cerebral perfusion pressure was consistently increased. Blood osmolarity rose by 9 mmol/L and serum sodium by 5.6 mmol/L. Potassium levels, hemoglobin, hematocrit, and pH were slightly decreased. No unexpected side effects were noted.
Conclusions— Infusion of 75 mL hypertonic (10%) saline decreases elevated ICP and increases cerebral perfusion pressure in stroke patients in whom mannitol had failed. The effect on the ICP and cerebral perfusion pressure reaches its maximum after the end of infusion and is seen for 4 hours.
Key Words: brain edema • hypertonic solution, saline • intracranial pressure • stroke
This article has been cited by other articles:
 |
|
 |
|
  M. A. Koenig, M. Bryan, J. L. Lewin III, M. A. Mirski, R. G. Geocadin, and R. D. Stevens Reversal of transtentorial herniation with hypertonic saline Neurology, March 25, 2008; 70(13): 1023 - 1029. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Bardutzky and S. Schwab Antiedema Therapy in Ischemic Stroke Stroke, November 1, 2007; 38(11): 3084 - 3094. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. White, D. Cook, and B. Venkatesh The use of hypertonic saline for treating intracranial hypertension after traumatic brain injury. Anesth. Analg., June 1, 2006; 102(6): 1836 - 1846. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Copp, S. Wiley, M. W. Ward, and P. van der Geer Hypertonic shock inhibits growth factor receptor signaling, induces caspase-3 activation, and causes reversible fragmentation of the mitochondrial network Am J Physiol Cell Physiol, February 1, 2005; 288(2): C403 - C415. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M.-Y. Tseng, P. G. Al-Rawi, J. D. Pickard, F. A. Rasulo, and P. J. Kirkpatrick Effect of Hypertonic Saline on Cerebral Blood Flow in Poor-Grade Patients With Subarachnoid Hemorrhage Stroke, June 1, 2003; 34(6): 1389 - 1396. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. C. Ziai, M. A. Mirski, A. Bhardwaj, S. Schwarz, D. Georgiadis, S. Schwab, and A. Aschoff Use of Hypertonic Saline in Ischemic Stroke Stroke, April 1, 2002; 33(4): 1166 - 1167. [Full Text] [PDF]
|
|